Mengli Xu - Search Results

Year	Number of Results
2020	6
2021	2
2022	7
2023	7
2024	4

1

Mendelian randomization and transcriptomic analysis reveal an inverse causal relationship between Alzheimer's disease and cancer.

Dong Z, Xu M, Sun X, Wang X. Dong Z, et al. Among authors: xu m. J Transl Med. 2023 Aug 4;21(1):527. doi: 10.1186/s12967-023-04357-3. J Transl Med. 2023. PMID: 37542274 Free PMC article.

2

2,4,6-Triphenyl-N-{(3E)-3-[(2,4,6-tri-phenyl-phen-yl)imino]-butan-2-yl-idene}aniline.

Zhang Y, Yu F, Li P, Xu M, Xu G, Li W, Wang F. Zhang Y, et al. Among authors: xu m. IUCrdata. 2020 Apr 30;5(Pt 4):x200531. doi: 10.1107/S2414314620005313. eCollection 2020 Apr. IUCrdata. 2020. PMID: 36338300 Free PMC article.

3

Ion Transport in pH-Regulated Double-Barreled Nanopores.

Zhang X, Xu M, Yang J, Hu N. Zhang X, et al. Among authors: xu m. Anal Chem. 2022 Apr 12;94(14):5642-5650. doi: 10.1021/acs.analchem.1c05654. Epub 2022 Mar 30. Anal Chem. 2022. PMID: 35352923

4

Macrophages play a key role in tissue repair and regeneration.

Yu Y, Yue Z, Xu M, Zhang M, Shen X, Ma Z, Li J, Xie X. Yu Y, et al. Among authors: xu m. PeerJ. 2022 Sep 29;10:e14053. doi: 10.7717/peerj.14053. eCollection 2022. PeerJ. 2022. PMID: 36196399 Free PMC article. Review.

5

Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial.

Meng X, Wu T, Hong Y, Fan Q, Ren Z, Guo Y, Yang X, Shi P, Yang J, Yin X, Luo Z, Xia J, Zhou Y, Xu M, Liu E, Jiang G, Li S, Zhao F, Ma C, Ma C, Hou Z, Li J, Wang J, Wang F. Meng X, et al. Among authors: xu m. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):245-253. doi: 10.1016/S2468-1253(21)00378-2. Epub 2022 Jan 6. Lancet Gastroenterol Hepatol. 2022. PMID: 34998471 Clinical Trial.

6

Controllable and Stable Fusion Strategy on Microfluidics.

Bai Y, Zhang X, Wang X, Xu M, Yang J, Hu N. Bai Y, et al. Among authors: xu m. Anal Chem. 2024 Mar 19;96(11):4437-4445. doi: 10.1021/acs.analchem.3c04592. Epub 2024 Mar 5. Anal Chem. 2024. PMID: 38501259

7

Trapping and releasing of single microparticles and cells in a microfluidic chip.

Lv D, Zhang X, Xu M, Cao W, Liu X, Deng J, Yang J, Hu N. Lv D, et al. Among authors: xu m. Electrophoresis. 2022 Nov;43(21-22):2165-2174. doi: 10.1002/elps.202200091. Epub 2022 Jul 3. Electrophoresis. 2022. PMID: 35730632

8

Mesoscale visualization of three-dimensional microvascular architecture and immunocyte distribution in intact mouse liver lobes.

Liu Z, Xu M, Huang S, Pan Q, Liu C, Zeng F, Fan Z, Lu Y, Wang J, Liu J, Li X, Luo Q, Zhang Z. Liu Z, et al. Among authors: xu m. Theranostics. 2022 Jul 11;12(12):5418-5433. doi: 10.7150/thno.71718. eCollection 2022. Theranostics. 2022. PMID: 35910800 Free PMC article.

9

Melittin-Carrying Nanoparticle Suppress T Cell-Driven Immunity in a Murine Allergic Dermatitis Model.

Liu Z, Fan Z, Liu J, Wang J, Xu M, Li X, Xu Y, Lu Y, Han C, Zhang Z. Liu Z, et al. Among authors: xu m. Adv Sci (Weinh). 2023 Mar;10(7):e2204184. doi: 10.1002/advs.202204184. Epub 2023 Jan 13. Adv Sci (Weinh). 2023. PMID: 36638280 Free PMC article.

10

PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy as First-line Treatment for Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.

Lu Y, Xu M, Guan L, Yang Y, Chen Y, Yang Y, Wang F. Lu Y, et al. Among authors: xu m. J Immunother. 2022 Jun 1;45(5):243-253. doi: 10.1097/CJI.0000000000000420. Epub 2022 Apr 26. J Immunother. 2022. PMID: 35467579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year